Tags

Type your tag names separated by a space and hit enter

A full-UV spectrum absorbing daily use cream protects human skin against biological changes occurring in photoaging.
Photodermatol Photoimmunol Photomed. 2000 Aug; 16(4):147-55.PP

Abstract

BACKGROUND

There is overwhelming evidence that exposure of human skin to ultraviolet radiations (UVR) leads to the development of cutaneous photoaging and eventually to neoplasia. This study was designed to evaluate in humans the protection afforded by a daily use cream containing a photostable combination of UVB and UVA absorbers (Uvinul N539, Parsol 1789 and Mexoryl SX) providing a continuous absorption through the entire UV spectrum, against damages induced by repeated daily exposure to solar simulated radiation (SSR).

METHODS

Buttock skin of 12 healthy volunteers was exposed 5 days per week for 6 weeks to one minimal erythema dose of solar simulated radiation per exposure. The following parameters in treated and untreated skin were evaluated: erythema, pigmentation, skin hydration, skin microtopography, histology and immunochemistry, and collagen and metalloproteinase (MMP) mRNA levels.

RESULTS

In SSR exposed unprotected skin sites, we observed melanization and changes in the skin hydration and microtopography. The epidermis revealed a significant increase in stratum corneum and stratum granulosum thickness. In the dermis, an enhanced expression of tenascin and a reduced expression of type I pro-collagen were evidenced just below the dermal epidermal junction. Although we were unable to visualize any change in elastic fibers in exposed buttock skin, a slightly increased deposition of lysozyme and alpha 1 antitrypsin on these fibers was observed using immunofluorescence techniques. Furthermore, types I and III collagen mRNA were slightly increased and a significant enhancement (up to 2.8-fold) of MMP-2 mRNA level was observed. The daily use cream was shown to prevent all these biological changes.

CONCLUSION

Our results show in vivo that an appropriate full-UV spectrum product significantly reduces the solar-UV-induced skin damage, demonstrating the benefit of daily photoprotection.

Authors+Show Affiliations

L'OREAL, Centre de Recherche Charles Zviak, Clichy, France.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

11019938

Citation

Seité, S, et al. "A full-UV Spectrum Absorbing Daily Use Cream Protects Human Skin Against Biological Changes Occurring in Photoaging." Photodermatology, Photoimmunology & Photomedicine, vol. 16, no. 4, 2000, pp. 147-55.
Seité S, Colige A, Piquemal-Vivenot P, et al. A full-UV spectrum absorbing daily use cream protects human skin against biological changes occurring in photoaging. Photodermatol Photoimmunol Photomed. 2000;16(4):147-55.
Seité, S., Colige, A., Piquemal-Vivenot, P., Montastier, C., Fourtanier, A., Lapière, C., & Nusgens, B. (2000). A full-UV spectrum absorbing daily use cream protects human skin against biological changes occurring in photoaging. Photodermatology, Photoimmunology & Photomedicine, 16(4), 147-55.
Seité S, et al. A full-UV Spectrum Absorbing Daily Use Cream Protects Human Skin Against Biological Changes Occurring in Photoaging. Photodermatol Photoimmunol Photomed. 2000;16(4):147-55. PubMed PMID: 11019938.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - A full-UV spectrum absorbing daily use cream protects human skin against biological changes occurring in photoaging. AU - Seité,S, AU - Colige,A, AU - Piquemal-Vivenot,P, AU - Montastier,C, AU - Fourtanier,A, AU - Lapière,C, AU - Nusgens,B, PY - 2000/10/6/pubmed PY - 2001/3/7/medline PY - 2000/10/6/entrez SP - 147 EP - 55 JF - Photodermatology, photoimmunology & photomedicine JO - Photodermatol Photoimmunol Photomed VL - 16 IS - 4 N2 - BACKGROUND: There is overwhelming evidence that exposure of human skin to ultraviolet radiations (UVR) leads to the development of cutaneous photoaging and eventually to neoplasia. This study was designed to evaluate in humans the protection afforded by a daily use cream containing a photostable combination of UVB and UVA absorbers (Uvinul N539, Parsol 1789 and Mexoryl SX) providing a continuous absorption through the entire UV spectrum, against damages induced by repeated daily exposure to solar simulated radiation (SSR). METHODS: Buttock skin of 12 healthy volunteers was exposed 5 days per week for 6 weeks to one minimal erythema dose of solar simulated radiation per exposure. The following parameters in treated and untreated skin were evaluated: erythema, pigmentation, skin hydration, skin microtopography, histology and immunochemistry, and collagen and metalloproteinase (MMP) mRNA levels. RESULTS: In SSR exposed unprotected skin sites, we observed melanization and changes in the skin hydration and microtopography. The epidermis revealed a significant increase in stratum corneum and stratum granulosum thickness. In the dermis, an enhanced expression of tenascin and a reduced expression of type I pro-collagen were evidenced just below the dermal epidermal junction. Although we were unable to visualize any change in elastic fibers in exposed buttock skin, a slightly increased deposition of lysozyme and alpha 1 antitrypsin on these fibers was observed using immunofluorescence techniques. Furthermore, types I and III collagen mRNA were slightly increased and a significant enhancement (up to 2.8-fold) of MMP-2 mRNA level was observed. The daily use cream was shown to prevent all these biological changes. CONCLUSION: Our results show in vivo that an appropriate full-UV spectrum product significantly reduces the solar-UV-induced skin damage, demonstrating the benefit of daily photoprotection. SN - 0905-4383 UR - https://www.unboundmedicine.com/medline/citation/11019938/A_full_UV_spectrum_absorbing_daily_use_cream_protects_human_skin_against_biological_changes_occurring_in_photoaging_ L2 - https://onlinelibrary.wiley.com/resolve/openurl?genre=article&sid=nlm:pubmed&issn=0905-4383&date=2000&volume=16&issue=4&spage=147 DB - PRIME DP - Unbound Medicine ER -